News Detail
Washington, 24 Oct 2024: Merck has acquired Modifi Biosciences, a biotechnology company focused on direct DNA modification-enabled cancer therapeutics, for up to $1.3bn
As per the terms of the agreement, Merck has acquired all outstanding shares of Modifi B......
View Details
Source : World Pharmaceutical Frontiers
Merck
Modifi Biosciences
cancer therapy
glioblastomas
biotech firm
experimental therapies
brain tumors
Daiichi Sankyo
Related News
- Private hospitals in UP will not be able to sell medicines of their choice (28-10-2024)
- No violation of Abbott's trademark: Delhi HC upholds trademark of Mebufen against Brufen (27-10-2024)
- BCI removes 107 fake advocates from Delhi roll (27-10-2024)
- Rewa police action against narcotic cough syrup, seized goods worth Rs 7 lakhs (27-10-2024)
- FDA seizes ₹1 crore stock for misleading claims (27-10-2024)
- One more case of making 12th pass as doctor has come to light again in Rajasthan (26-10-2024)
- 9 arrested in Excise Department action, 1500 bottles of cough syrup and four wheeler recovered (26-10-2024)
- Fake medicine were being made in toffee factory, Rs 80 crore Medicines sold in the market (26-10-2024)
- Centre issues revised list of refurbished medical equipment for import; industry reacts sharply (26-10-2024)
- Ensure Tamil university diploma holders don’t practise Siddha, Madras HC tells govt (26-10-2024)